Targeting nucleolin for better survival in diffuse large B-cell lymphoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting nucleolin for better survival in diffuse large B-cell lymphoma
Authors
Keywords
-
Journal
LEUKEMIA
Volume 32, Issue 3, Pages 663-674
Publisher
Springer Nature
Online
2017-07-10
DOI
10.1038/leu.2017.215
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature
- (2016) Maud-Emmanuelle Gilles et al. CANCER RESEARCH
- Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs
- (2016) Rohit Mathur et al. HAEMATOLOGICA
- AS1411 Aptamer-Decorated Biodegradable Polyethylene Glycol–Poly(lactic-co-glycolic acid) Nanopolymersomes for the Targeted Delivery of Gemcitabine to Non–Small Cell Lung Cancer In Vitro
- (2016) Mona Alibolandi et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs
- (2016) Rohit Mathur et al. HAEMATOLOGICA
- The roles of nucleolin subcellular localization in cancer
- (2015) Caroline Madeleine Berger et al. BIOCHIMIE
- Molecular difference between WASP and N-WASP critical for chemotaxis of T-cells towards SDF-1α
- (2015) Neeraj Jain et al. Scientific Reports
- A Synthetic Aptamer-Drug Adduct for Targeted Liver Cancer Therapy
- (2015) Thu Le Trinh et al. PLoS One
- Cell Surface Nucleolin as a Target for Anti-Cancer Therapies
- (2014) Marina Koutsioumpa et al. Recent Patents on Anti-Cancer Drug Discovery
- Overexpression of nucleolin and different expression sites both related to the prognosis of gastric cancer
- (2013) Wensheng Qiu et al. APMIS
- Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex
- (2013) J. F. Wise et al. BLOOD
- In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation
- (2013) Flavia Pichiorri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Nucleolin Interacts with the Dengue Virus Capsid Protein and Plays a Role in Formation of Infectious Virus Particles
- (2013) C. A. Balinsky et al. JOURNAL OF VIROLOGY
- Nucleolin is important for Epstein-Barr virus nuclear antigen 1-mediated episome binding, maintenance, and transcription
- (2013) Y.-L. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nucleolin mediates nucleosome disruption critical for DNA double-strand break repair
- (2013) M. Goldstein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
- (2012) Z. Y. Xu-Monette et al. BLOOD
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Inhibition of ATM blocks the etoposide-induced DNA damage response and apoptosis of resting human T cells
- (2012) Z. Korwek et al. DNA REPAIR
- Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study
- (2012) C. Visco et al. HAEMATOLOGICA
- Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
- (2012) C Visco et al. LEUKEMIA
- Nucleolin Participates in DNA Double-Strand Break-Induced Damage Response through MDC1-Dependent Pathway
- (2012) Junya Kobayashi et al. PLoS One
- RNA-binding protein nucleolin in disease
- (2012) Kotb Abdelmohsen et al. RNA Biology
- Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type
- (2011) Bernard Krust et al. BMC CANCER
- A Simple Approach to Cancer Therapy Afforded by Multivalent Pseudopeptides That Target Cell-Surface Nucleoproteins
- (2011) D. Destouches et al. CANCER RESEARCH
- Peptidyl Prolyl Isomerase, Pin1 is a Potential Target for Enhancing the Therapeutic Efficacy of Etoposide
- (2011) R. Mathur et al. CURRENT CANCER DRUG TARGETS
- Topo IIα gene alterations correlated with survival in patients with diffuse large B-cell lymphoma
- (2011) Zhenwen Chen et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Identification of nucleolin as a cellular receptor for human respiratory syncytial virus
- (2011) Farnoosh Tayyari et al. NATURE MEDICINE
- Ku70 and Rad51 vary in their importance for the repair of doxorubicin- versus etoposide-induced DNA damage
- (2010) Ilona Schonn et al. APOPTOSIS
- DNA Topoisomerase II Enzymes as Molecular Targets for Cancer Chemotherapy
- (2010) K. Chikamori et al. CURRENT CANCER DRUG TARGETS
- Alteration of Topoisomerase II–Alpha Gene in Human Breast Cancer: Association With Responsiveness to Anthracycline-Based Chemotherapy
- (2010) Michael F. Press et al. JOURNAL OF CLINICAL ONCOLOGY
- γH2AX: a sensitive molecular marker of DNA damage and repair
- (2010) L-J Mah et al. LEUKEMIA
- High levels of topoisomerase IIα protein expression in diffuse large B-cell lymphoma are associated with high proliferation, germinal center immunophenotype, and response to treatment
- (2010) George Pentheroudakis et al. LEUKEMIA & LYMPHOMA
- Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature
- (2009) Valentina Fogal et al. ANGIOGENESIS
- Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
- (2009) Paula J. Bates et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- The DNA-damage response in human biology and disease
- (2009) Stephen P. Jackson et al. NATURE
- Diffuse Large B-Cell Lymphoma
- (2008) Jonathan W. Friedberg et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Stromal Gene Signatures in Large-B-Cell Lymphomas
- (2008) G. Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Casein kinase I / phosphorylates topoisomerase II at serine-1106 and modulates DNA cleavage activity
- (2008) A. G. Grozav et al. NUCLEIC ACIDS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More